These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 17070484
1. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma. Sabri K, Levin AV. J AAPOS; 2006 Oct; 10(5):464-8. PubMed ID: 17070484 [Abstract] [Full Text] [Related]
2. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma. Portellos M, Buckley EG, Freedman SF. J AAPOS; 1998 Feb; 2(1):43-7. PubMed ID: 10532366 [Abstract] [Full Text] [Related]
3. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation. Rosenberg LF, Krupin T, Tang LQ, Hong PH, Ruderman JM. Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783 [Abstract] [Full Text] [Related]
4. Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol. Stewart WC, Halper LK, Johnson-Pratt L, Polis A, Hartenbaum D. J Ocul Pharmacol Ther; 2002 Jun; 18(3):211-20. PubMed ID: 12099542 [Abstract] [Full Text] [Related]
6. Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma. Lorenz K, Wasielica-Poslednik J, Bell K, Renieri G, Keicher A, Ruckes C, Pfeiffer N, Thieme H. PLoS One; 2017 Oct; 12(2):e0171636. PubMed ID: 28199397 [Abstract] [Full Text] [Related]
7. [Treatment of glaucoma with carbonic anhydrase inhibitors in eyewash: medium term retrospective experience with dorzolamide]. Detry-Morel M, De Hoste F. Bull Soc Belge Ophtalmol; 1997 Oct; 267():157-66. PubMed ID: 9745826 [Abstract] [Full Text] [Related]
8. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs. Gelatt KN, MacKay EO. Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321 [Abstract] [Full Text] [Related]
9. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial. Maruyama K, Shirato S. J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013 [Abstract] [Full Text] [Related]
10. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery. Zohdy GA, Rogers ZA, Lukaris A, Sells M, Roberts-Harry TJ. J R Coll Surg Edinb; 1998 Oct; 43(5):344-6. PubMed ID: 9803110 [Abstract] [Full Text] [Related]
11. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma]. Schmidt KG, von Rückmann A, Becker R, Pillunat LE. Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801 [Abstract] [Full Text] [Related]
12. [Trusopt--a new form of drug for treating glaucoma]. Izdebska J. Klin Oczna; 1997 Dec; 99(3):217-20. PubMed ID: 9456571 [Abstract] [Full Text] [Related]
13. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma. Scardillo A, Pugliese M, De Majo M, Niutta PP, Pugliese A. Vet Ther; 2010 Dec; 11(3):E1-6. PubMed ID: 20960417 [Abstract] [Full Text] [Related]
14. A trial of dorzolamide for glaucoma. Gillies WE, Brooks AM. Ophthalmic Surg Lasers; 1998 Sep; 29(9):728-32. PubMed ID: 9760608 [Abstract] [Full Text] [Related]
15. Comparative effects of intraocular pressure between systemic and topical carbonic anhydrase inhibitors: a clinical masked, cross-over study. Centofanti M, Manni GL, Napoli D, Bucci MG. Pharmacol Res; 1997 May; 35(5):481-5. PubMed ID: 9299215 [Abstract] [Full Text] [Related]
16. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Maus TL, Larsson LI, McLaren JW, Brubaker RF. Arch Ophthalmol; 1997 Jan; 115(1):45-9. PubMed ID: 9006424 [Abstract] [Full Text] [Related]
19. A topical or oral carbonic anhydrase inhibitor to control ocular hypertension after cataract surgery. Abbasoğlu E, Tekeli O, Celikdoğan A, Gürsel E. Eur J Ophthalmol; 2000 Jan; 10(1):27-31. PubMed ID: 10744202 [Abstract] [Full Text] [Related]